{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:53:29Z","timestamp":1790924009452,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V026097\/1"],"award-info":[{"award-number":["MR\/V026097\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V026097\/1"],"award-info":[{"award-number":["MR\/V026097\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Our primary objective was to identify the rate of antifungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects\/methods<\/jats:title>\n                    <jats:p>\n                      153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May\u2013August 2025) with culture-positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole minimum inhibitory concentration (MIC;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009151\u2013153). MIC data were analysed by Kruskal-Wallis test followed by Dunn\u2019s multiple comparisons. Patient disease outcome relative to isolate resistance was analysed by Fisher\u2019s exact test (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200991).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were high levels of resistance to all four antifungals, which were significantly elevated in\n                      <jats:italic>Fusarium<\/jats:italic>\n                      spp. and\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      spp. isolates compared to other fungal genera (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                      <jats:italic>Fusarium<\/jats:italic>\n                      spp. isolates (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200981) resistant to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5%; and econazole: 76.5%.\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      spp. isolates (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933) resistant to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with an adverse clinical outcome,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0034, relative risk 1.7 (95% CI: 1.2\u20132.6).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, and 28% were resistant to all of them. Resistance to natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus, even when susceptible to azoles. Our data support the need for species-specific MIC thresholds to have increased clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04938-8","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:05:46Z","timestamp":1790877946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidrug antifungal resistance and clinical outcomes in fungal keratitis: a prospective study in a South Indian population"],"prefix":"10.1038","author":[{"given":"Leonie","family":"Fingerhut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishnan","family":"Vigneshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Burt\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojkumar Vimala","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathinavel Sethu","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarathinam","family":"Karpagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-4044","authenticated-orcid":false,"given":"Venkatesh","family":"Prajna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-9490","authenticated-orcid":false,"given":"Bethany","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajna","family":"Lalitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"4938_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/jof7040273","volume":"7","author":"JJ Hoffman","year":"2021","unstructured":"Hoffman JJ, Burton MJ, Leck A. Mycotic Keratitis\u2014a global threat from the filamentous fungi. J Fungi. 2021;7:273 https:\/\/doi.org\/10.3390\/jof7040273.","journal-title":"J Fungi"},{"key":"4938_CR2","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/S1473-3099(20)30448-5","volume":"21","author":"L Brown","year":"2021","unstructured":"Brown L, Leck AK, Gichangi M, Burton MJ, Denning DW. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis. 2021;21:e49\u2013e57 https:\/\/doi.org\/10.1016\/S1473-3099(20)30448-5.","journal-title":"Lancet Infect Dis"},{"key":"4938_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ajo.2016.05.021","volume":"168","author":"HS Ong","year":"2016","unstructured":"Ong HS, Fung SSM, Macleod D, Dart JKG, Tuft SJ, Burton MJ. Altered patterns of fungal keratitis at a London ophthalmic referral hospital: an eight-year retrospective observational study. Am J Ophthalmol. 2016;168:227\u201336 https:\/\/doi.org\/10.1016\/j.ajo.2016.05.021.","journal-title":"Am J Ophthalmol"},{"key":"4938_CR4","doi-asserted-by":"publisher","unstructured":"Fingerhut L, Cheng KKW, Ali A, Mills B. Implications of fungal biofilms in microbial keratitis. Fungal Biofilms. 2025:335\u201394.https:\/\/doi.org\/10.1007\/978-3-031-93315-8_15.","DOI":"10.1007\/978-3-031-93315-8_15"},{"key":"4938_CR5","doi-asserted-by":"publisher","unstructured":"Janmohamed IK, Oguntoye O, Fu L, Robson C, Elalfy M, Maqsood S. 10-year analysis of microbiological profiles and in vitro antimicrobial susceptibility: the Kent microbial keratitis study. Eye. 2026:1\u20139.https:\/\/doi.org\/10.1038\/s41433-026-04302-w.","DOI":"10.1038\/s41433-026-04302-w"},{"key":"4938_CR6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/jof8101047","volume":"8","author":"L Brown","year":"2022","unstructured":"Brown L, Kamwiziku G, Oladele RO, Burton MJ, Prajna NV, Leitman TM, et al. The case for fungal keratitis to be accepted as a neglected tropical disease. J Fungi. 2022;8:1047 https:\/\/doi.org\/10.3390\/jof8101047.","journal-title":"J Fungi"},{"key":"4938_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2471\/BLT.19.232660","volume":"97","author":"L Ung","year":"2019","unstructured":"Ung L, Acharya NR, Agarwal T, Alfonso EC, Bagga B, Bispo PJ, et al. Infectious corneal ulceration: a proposal for neglected tropical disease status. Bull World Health Organ. 2019;97:854\u20136 https:\/\/doi.org\/10.2471\/BLT.19.232660.","journal-title":"Bull World Health Organ"},{"key":"4938_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108372","volume":"202","author":"B Mills","year":"2021","unstructured":"Mills B, Radhakrishnan N, Karthikeyan Rajapandian SG, Rameshkumar G, Lalitha P, Prajna NV. The role of fungi in fungal keratitis. Exp Eye Res. 2021;202:108372 https:\/\/doi.org\/10.1016\/j.exer.2020.108372.","journal-title":"Exp Eye Res"},{"key":"4938_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaophthalmol.2013.1612","volume":"131","author":"NV Prajna","year":"2013","unstructured":"Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, et al. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol. 2013;131:1088\u20139 https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.1612.","journal-title":"JAMA Ophthalmol"},{"key":"4938_CR10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/jof8101067","volume":"8","author":"JJ Hoffman","year":"2022","unstructured":"Hoffman JJ, Arunga S, Mohamed Ahmed AH, Hu VH, Burton MJ. Management of filamentous fungal keratitis: a pragmatic approach. J Fungi. 2022;8:1067 https:\/\/doi.org\/10.3390\/jof8101067.","journal-title":"J Fungi"},{"key":"4938_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/OPTH.S447138","volume":"18","author":"R Awad","year":"2024","unstructured":"Awad R, Ghaith AA, Awad K, Mamdouh Saad M, Elmassry AA. Fungal keratitis: diagnosis, management, and recent advances. Clin Ophthalmol. 2024;18:85\u2013106 https:\/\/doi.org\/10.2147\/OPTH.S447138.","journal-title":"Clin Ophthalmol"},{"key":"4938_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jamaophthalmol.2021.5765","volume":"140","author":"NV Prajna","year":"2022","unstructured":"Prajna NV, Lalitha P, Krishnan T, Rajaraman R, Radnakrishnan N, Srinivasan M, et al. Patterns of antifungal resistance in adult patients with fungal keratitis in South India: a post hoc analysis of 3 randomized clinical trials. JAMA Ophthalmol. 2022;140:179\u201384 https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.5765.","journal-title":"JAMA Ophthalmol"},{"key":"4938_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","volume":"131","author":"NV Prajna","year":"2013","unstructured":"Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131:422\u20139 https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.1497.","journal-title":"JAMA Ophthalmol"},{"key":"4938_CR14","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17:e383\u2013e92 https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X.","journal-title":"Lancet Infect Dis"},{"key":"4938_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aap7999","volume":"360","author":"MC Fisher","year":"2018","unstructured":"Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360:739\u201342 https:\/\/doi.org\/10.1126\/science.aap7999.","journal-title":"Science"},{"key":"4938_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1874364101913010100","volume":"13","author":"C Bartimote","year":"2019","unstructured":"Bartimote C, Foster J, Watson S. The spectrum of microbial keratitis: an updated review. Open Ophthalmol J. 2019;13:100\u201330 https:\/\/doi.org\/10.2174\/1874364101913010100.","journal-title":"Open Ophthalmol J"},{"key":"4938_CR17","unstructured":"World Health Organization, 2022. WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"4938_CR18","doi-asserted-by":"publisher","unstructured":"Antibiotic Resistance Threats in the United States. US Department of Health and Human Services, CDC. 2019 https:\/\/doi.org\/10.15620\/cdc:82532.","DOI":"10.15620\/cdc:82532"},{"key":"4938_CR19","unstructured":"CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 3rd ed. CLSI standard M38. Wayne: Clinical and Laboratory Standards Institute; 2017."},{"key":"4938_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41433-023-02719-1","volume":"38","author":"S Tuft","year":"2024","unstructured":"Tuft S, Stone NRH, Burton MJ, Johnson EM, Borman AM. Antifungal susceptibility profiles for fungal isolates from corneas and contact lenses in the United Kingdom. Eye. 2024;38:529\u201336 https:\/\/doi.org\/10.1038\/s41433-023-02719-1.","journal-title":"Eye"},{"key":"4938_CR21","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway JR, Lex A, Gehlenborg N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 2017;33:2938\u201340.","journal-title":"Bioinformatics"},{"key":"4938_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.fbr.2020.10.003","volume":"34","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Lucas JA, Arendrup MC, Bowyer P, Brinkmann AJF, Denning DW, et al. The one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda. Fungal Biol Rev. 2020;34:202\u201314 https:\/\/doi.org\/10.1016\/j.fbr.2020.10.003.","journal-title":"Fungal Biol Rev"},{"key":"4938_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamaophthalmol.2013.1718","volume":"131","author":"KJ Ray","year":"2013","unstructured":"Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013;131:310\u20133 https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.1718.","journal-title":"JAMA Ophthalmol"},{"key":"4938_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s44259-024-00055-2","volume":"2","author":"MC Fisher","year":"2024","unstructured":"Fisher MC, Burnett F, Chandler C, Gow NA, Gurr S, Hart A, et al. A one health roadmap towards understanding and mitigating emerging fungal antimicrobial resistance: fAMR. NPJ Antimicrob Resist. 2024;2:36.","journal-title":"NPJ Antimicrob Resist"},{"key":"4938_CR25","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41564-025-02055-y","volume":"10","author":"N van Rhijn","year":"2025","unstructured":"van Rhijn N, Rhodes J. Evolution of antifungal resistance in the environment. Nat Microbiol. 2025;10:1804\u201315.","journal-title":"Nat Microbiol"},{"key":"4938_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1094182","volume":"13","author":"M Soleimani","year":"2023","unstructured":"Soleimani M, Izadi A, Khodavaisy S, Dos Santos CO, Tehupeiory-Kooreman MC, Ghazvini RD, et al. Fungal keratitis in Iran: risk factors, clinical features, and mycological profile. Front Cell Infect Microbiol. 2023;13:1094182 https:\/\/doi.org\/10.3389\/fcimb.2023.1094182.","journal-title":"Front Cell Infect Microbiol"},{"key":"4938_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajo.2008.04.019","volume":"146","author":"L Xie","year":"2008","unstructured":"Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol. 2008;146:260\u20135 https:\/\/doi.org\/10.1016\/j.ajo.2008.04.019.","journal-title":"Am J Ophthalmol"},{"key":"4938_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6395840","volume":"2019","author":"P Manikandan","year":"2019","unstructured":"Manikandan P, Abdel-Hadi A, Randhir Babu Singh Y, Revathi R, Anita R, Banawas S, et al. Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of Fusarium and Aspergillus isolates from corneal scrapings. Biomed Res Int. 2019;2019:6395840 https:\/\/doi.org\/10.1155\/2019\/6395840.","journal-title":"Biomed Res Int"},{"key":"4938_CR29","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ophtha.2014.03.004","volume":"121","author":"CQ Sun","year":"2014","unstructured":"Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O\u2019Brien KS, et al. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. Ophthalmology. 2014;121:1495\u2013500 e1 https:\/\/doi.org\/10.1016\/j.ophtha.2014.03.004.","journal-title":"Ophthalmology"},{"key":"4938_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-024-00418-w","volume":"14","author":"L Lu","year":"2024","unstructured":"Lu L, Prajna NV, Lalitha P, Rajaraman R, Srinivasan M, Arnold BF, et al. Association between in vitro susceptibility and clinical outcomes in fungal keratitis. J Ophthalmic Inflamm Infect. 2024;14:42 https:\/\/doi.org\/10.1186\/s12348-024-00418-w.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"4938_CR31","doi-asserted-by":"publisher","first-page":"7774","DOI":"10.1167\/iovs.12-10810","volume":"53","author":"X Zhang","year":"2012","unstructured":"Zhang X, Sun X, Wang Z, Zhang Y, Hou W. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Investig Ophthalmol Vis Sci. 2012;53:7774\u20138 https:\/\/doi.org\/10.1167\/iovs.12-10810.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4938_CR32","doi-asserted-by":"publisher","unstructured":"Lass-Fl\u00f6rl C, Lass M, Kern JM, Huber S. Antifungal susceptibility testing across fungi: why MICs vary, methods diverge, and what MIC can miss. Clin Microbiol Infect. 2026 https:\/\/doi.org\/10.1016\/j.cmi.2026.03.004.","DOI":"10.1016\/j.cmi.2026.03.004"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04938-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04938-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04938-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:01:44Z","timestamp":1790920904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04938-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":32,"alternative-id":["4938"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04938-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was approved by the Institutional Review Board of Aravind Eye Hospital, Madurai (RET202500520).","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}